India Globalization Capit... (IGC)
AMEX: IGC
· Real-Time Price · USD
0.31
0.00 (1.11%)
At close: Jun 09, 2025, 3:56 PM
1.11% (1D)
| Bid | 0.31 |
| Market Cap | 25.09M |
| Revenue (ttm) | 1.24M |
| Net Income (ttm) | -8.81M |
| EPS (ttm) | -0.12 |
| PE Ratio (ttm) | -2.62 |
| Forward PE | -3.05 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 0.32 |
| Volume | 98,272 |
| Avg. Volume (20D) | 265,536 |
| Open | 0.31 |
| Previous Close | 0.31 |
| Day's Range | 0.31 - 0.32 |
| 52-Week Range | 0.25 - 0.55 |
| Beta | 1.48 |
| Ex-Dividend Date | n/a |
India Globalization Capital Inc. is scheduled to release its earnings on
Jun 23, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 year ago
+20.56%
Shares of cannabis stocks are trading higher follo...
Unlock content with
Pro Subscription
1 year ago
+1.17%
IGC Pharma shares are trading higher after a Form 4 filing showed that company director James P. Moran purchased 588,235 shares of common stock at $0.34 per share.
6 months ago · accessnewswire.com
IGC Pharma Announces CALMA Phase 2 Trial Expansion with the Addition of Miami Jewish HealthPOTOMAC, MD / ACCESS Newswire / April 1, 2025 / IGC Pharma, Inc. (NYSE American:IGC) today announced the expansion of its Phase 2 clinical trial, CALMA, evaluating IGC-AD1 for the treatment of agitati...
6 months ago · accessnewswire.com
IGC Pharma Expands CALMA Trial with Addition of BayCare Health System in FloridaPOTOMAC, MARYLAND / ACCESS Newswire / March 17, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") today announced the addition of a new trial site at BayCare's St. Anthony's ...
